Patients with systemic autoimmune rheumatic disease who develop interstitial lung disease have a similar 1-year mortality risk following either a single- or double-lung transplant, according to a study presented at ACR Convergence 2024. The study, conducted by Harry Hurley, MD, and colleagues, included 606 adults with SARD-ILD. The analysis showed that single-lung transplant did not result in significantly increased 1-year mortality compared to double-lung transplant. The findings suggest that single-lung transplants may be a reasonable strategy to increase the number of lungs available for transplantation in patients with late-stage lung disease from ILD and SARDs.
Source link
Mortality similar after single- vs double-lung transplant in autoimmune disease with ILD
